The DIDB team will be exhibiting at the 17th International Conference on Drug-Drug Interactions in Seattle on June 30-July 2, 2014, and will contribute to the scientific program with two presentations:
* Critical Review of the 2013-2014 Literature (Dr. Sophie Argon)
* New Molecular Entities Approved by FDA in 2013: Review of In Vitro and In Vivo Data (Dr. Jingjing Yu)
Dr. Ragueneau-Majlessi will be chairing the session entitled “NDA and Literature Update” on June 30th.